CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-04 | DENYES NANCY General Counsel | Sale | −1,118 | $0.98 | $1K | 33,124 |
| 2026-02-03 | DENYES NANCY General Counsel | Exercise or conversion | +2,687 | 34,242 | ||
| 2026-02-03 | DENYES NANCY General Counsel | Exercise or conversion · Restricted Stock Unit | −2,687 | 0 | ||
| 2026-01-09 | DENYES NANCY General Counsel | Grant or award · Employee Stock Options (right to buy) | +412,500 | 412,500 | ||
| 2025-02-04 | DENYES NANCY General Counsel | Sale | −899 | $3.78 | $3K | 26,555 |
| 2025-02-03 | DENYES NANCY General Counsel | Exercise or conversion | +2,687 | 27,454 | ||
| 2025-02-03 | DENYES NANCY General Counsel | Exercise or conversion · Restricted Stock Unit | −2,687 | 2,687 | ||
| 2025-01-08 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2024-06-05 | DENYES NANCY General Counsel | Purchase | +5,000 | $1.86 | $9K | 22,267 |
| 2024-02-05 | DENYES NANCY General Counsel | Exercise or conversion | +2,688 | 14,767 | ||
| 2024-02-05 | DENYES NANCY General Counsel | Exercise or conversion · Restricted Stock Unit | −2,688 | 5,374 | ||
| 2024-01-05 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-02-16 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +84,023 | 84,023 | ||
| 2023-02-03 | DENYES NANCY General Counsel | Exercise or conversion | +2,688 | 7,079 | ||
| 2023-02-03 | DENYES NANCY General Counsel | Exercise or conversion · Restricted Stock Unit | −2,688 | 8,062 | ||
| 2022-05-24 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +88,097 | 88,097 | ||
| 2022-02-03 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2022-02-03 | DENYES NANCY General Counsel | Grant or award · Restricted Stock Units | +10,750 | 10,750 | ||
| 2021-05-21 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (Right to buy) | +59,000 | 59,000 | ||
| 2021-02-04 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +45,000 | 45,000 |
Page 1 of 2 · 25 trades